The past is not always a prediction of the future,
Post# of 72435
![](/assets/46931549/no_avatar_available_thumb.jpg)
Wednesday, February 10, 2016
Cellceutix Meets With FDA for Phase 2 Clinical Trial of Kevetrin for Ovarian CancerMarketwired (Wed, Feb 10)
Tuesday, February 9, 2016
Cellceutix to Submit Special Protocol Assessment Request to FDA for Phase 3 Clinical Study of Antibiotic Brilacidin for ABSSSIMarketwired (Tue, Feb 9)
Monday, February 8, 2016
CELLCEUTIX CORP Files SEC form 10-Q, Quarterly ReportEDGAR Online (Mon, Feb
![8) 8)](smileys/bigeyes.gif)
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)